NCT01991223

Dexmedetomidine for Catheter-related Bladder Discomfort

Efficacy of Dexmedetomidine for the Therapy of Catheter-related Bladder Discomfort

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 114 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort

Detailed description

After transurethral bladder resection, large-sized foley catheter have been used for drainage of urine and residual blood. Because of urinary catheterization, patients usually experiences catheter-related bladder discomfort defined as a burning sensation with an urge to void or discomfort in the supra-pubic region caused by catheter- related bladder irritation. Dexmedetomidine is an alpha-2 antagonist and used as an analgesic agent. The investigators try to evaluate The efficacy of dexmedetomidine for the treatment of catheter-related bladder discomfort

Conditions

• Pain
• Blood Pressure
• Nausea
• Vomiting
• Arrhythmia

Interventions

Type	Name	Description
DRUG	Dex infusion	Dexmedetomidine will be injected (1 mcg/kg for 10 minutes and afterward 0.3 mcg/kg/hr)
DRUG	NS infusion	Normal saline will be infused during surgery

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2013-11-25
• Last updated: 2014-03-19

Locations

1 site across 1 country: South Korea